Search Results - "Montiel, Pilar Martínez"

Comparison of satisfaction degree of patients treated at the Inflammatory Bowel Disease Unit (IBDU) of Hospital Universitario 12 de Octubre between previous face-to-face care and telephone care during the COVID-19 pandemic by Vázquez García, Pablo, Fernández-Gordón Sánchez, Flor María, Algara San Nicolás, María, Yela San Bernardino, Carmen, Casis Herce, Begoña, Masedo González, Ángeles, Gómez Gómez, Gonzalo Jesús, Martínez Montiel, María Del Pilar

“…The aim of the IBDU is to provide comprehensive care for patients with IBD (1,2). During the COVID-19 pandemic, telephone medical consultations and…”
Get full text

Increased risk of thiopurine‐related adverse events in elderly patients with IBD by Calafat, Margalida, Mañosa, Míriam, Cañete, Fiorella, Ricart, Elena, Iglesias, Eva, Calvo, Marta, Rodríguez‐Moranta, Francisco, Taxonera, Carlos, Nos, Pilar, Mesonero, Francisco, Martín‐Arranz, María-Dolores, Mínguez, Miguel, Gisbert, Javier P., García‐López, Santiago, de Francisco, Ruth, Gomollón, Fernando, Calvet, Xavier, Garcia‐Planella, Esther, Rivero, Montserrat, Martínez‐Cadilla, Jesús, Argüelles, Federico, Arias, Lara, Cimavilla, Marta, Zabana, Yamile, Domènech, Eugeni, Abad, Àgueda, Alcaín, Guillermo, Almela, Pedro, Argüelles, Federico, Arias, Lara, Barreiro‐de‐Acosta, Manuel, Ber, Yolanda, Bermejo, Fernando, Bujanda, Luis, Busquets, David, Calafat, Margalida, Calvet, Xavier, Calvo, Marta, Cañete, Fiorella, Charro, Mara, Cimavilla, Marta, Domènech, Eugeni, Francisco, Ruth, García‐Bosch, Orlando, García‐López, Santiago, Garcia‐Planella, Esther, García‐Sepulcre, Mariana‐Fe, Gomollón, Fernando, Gutiérrez, Ana, Huguet, José M., Iglesias, Eva, Khorrami, Sam, Lázaro, José, Legido, Jesús, Llaó, Jordina, Lucendo, Alfredo J., Madrigal, Rosa E., Mañosa, Míriam, Márquez, Lucía, Dolores Martín‐Arranz, M., Martínez‐Cadilla, Jesús, Martínez‐Montiel, Pilar, Merino, Olga, Mesonero, Francisco, Mínguez, Miguel, Monfort, David, Mora, María, Muñoz‐Villafranca, Carmen, Nos, Pilar, Gisbert, Javier P., Ramos, Laura, Ricart, Elena, Riera, Joan, Rivero, Montserrat, Rodríguez Pérez, Antonio, Rodríguez Gutiérrez, Cristina, Rodríguez‐Moranta, Francisco, Rodríguez‐Pescador, Ainhoa, Romero, Patricia, Roncero, Oscar, Sesé, Eva, Taxonera, Carlos, Trapero, Ana M., Van Domselaar, Manuel, Vela, Milagros, Velayos, Benito, Verdejo, Cristina, Zabana, Yamile

“…Summary Background Thiopurines are the most widely used immunosuppressants in IBD although drug‐related adverse events (AE) occur in 20%‐30% of cases. Aim To…”
Get full text

Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn’s Disease: Real World Evidence From the ENEIDA Registry by Casas-Deza, Diego, Lamuela-Calvo, Luis Javier, Gomollón, Fernando, Arbonés-Mainar, José Miguel, Caballol, Berta, Gisbert, Javier P, Rivero, Montserrat, Sánchez-Rodríguez, Eugenia, Arias García, Lara, Gutiérrez Casbas, Ana, Merino, Olga, Márquez, Lucía, Laredo, Viviana, Martín-Arranz, María Dolores, López Serrano, Pilar, Riestra Menéndez, Sabino, González-Muñoza, Carlos, de Castro Parga, Luisa, Calvo Moya, Marta, Fuentes-Valenzuela, Esteban, Esteve, Maria, Iborra, Marisa, Dura Gil, Miguel, Barreiro-De Acosta, Manuel, Lorente-Poyatos, Rufo Humberto, Manceñido, Noemí, Calafat, Margalida, Rodríguez-Lago, Iago, Guardiola Capo, Jordi, Payeras, Maria Antonia, Morales Alvarado, Víctor Jair, Tardillo, Carlos, Bujanda, Luis, Muñoz-Nuñez, José Fernando, Ber Nieto, Yolanda, Bermejo, Fernando, Almela, Pedro, Navarro-Llavat, Mercè, Martínez Montiel, Pilar, Rodríguez Gutiérrez, Cristina, Van Domselaar, Manuel, Sesé, Eva, Martínez Pérez, Teresa, Ricart, Elena, Chaparro, María, García, María José, López-Sanromán, Antonio, Sicilia, Beatriz, Orts, Beatriz, López-García, Alicia, Martín-Arranz, Eduardo, Pérez-Calle, José Lázaro, de Francisco, Ruth, García-Planella, Esther, Domènech, Eugeni, García-López, y Santiago

“…Abstract Background and Aims Clinical trials and real-life studies with ustekinumab in Crohn’s disease [CD] have revealed a good efficacy and safety profile…”
Get full text

Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis by Taxonera, Carlos, Iborra, Marisa, Bosca-Watts, Marta Maia, Rubio, Saioa, Nantes, Óscar, Higuera, Rebeca, Bertoletti, Federico, Martínez-Montiel, Pilar, Sierra-Ausin, Mónica, Manceñido, Noemí, Lázaro Pérez-Calle, José, Algaba, Alicia, Olivares, David, Alba, Cristina

“…Aim: To evaluate outcomes of early dose optimization of golimumab in ulcerative colitis (UC) patients with inadequate response to golimumab induction…”
Get full text

Current stage in inflammatory bowel disease: What is next? by Gonzalo Jesús Gómez-Gómez ángeles Masedo Carmen Yela Maria del Pilar Martínez-Montiel Bego?a Casís

“…In recent years,the incidence of inflammatory bowel disease(IBD) has been on the rise,extending to countries where it was infrequent in the past. As a…”
Get full text

Therapy with stem cells in inflammatory bowel disease by Martínez-Montiel, María Del Pilar, Gómez-Gómez, Gonzalo Jesús, Flores, Ana Isabel

“…Inflammatory bowel disease(IBD) affects a part of the young population and has a strong impact upon quality of life. The underlying etiology is not known, and…”
Get full text

Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn’s patients: Results of the APPRECIA trial by Taxonera, Carlos, López-Sanromán, Antonio, Vera-Mendoza, Isabel, Domènech, Eugeni, Ruiz, Vicente Vega, Marín-Jiménez, Ignacio, Guardiola, Jordi, Castro, Luisa, Esteve, María, Iglesias, Eva, Ceballos, Daniel, Martínez-Montiel, Pilar, Gisbert, Javier P., Mínguez, Miguel, Echarri, Ana, Calvet, Xavier, Barrio, Jesús, Hinojosa, Joaquín, Martín-Arranz, María Dolores, Márquez-Mosquera, Lucía, Bermejo, Fernando, Rimola, Jordi, Alba, Cristina, Pons, Vicente, Nos, Pilar

“…In APPRECIA trial, Crohn's disease (CD) patients undergoing intestinal resection were randomized to postoperative adalimumab (ADA) or azathioprine (AZA). To…”
Get full text

Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL study by Taxonera, Carlos, Martínez-Montiel, María Pilar, Barreiro-de-Acosta, Manuel, Vera, Isabel, Lorente, Rufo, Vega, Pablo, Diz-Lois, María Teresa, Fuentes Coronel, Ana María, Pérez Calle, José Lázaro, Casis, Begoña, Ferreiro-Iglesias, Rocío, Calvo, Marta, Olivares, David, Alba, Cristina

“…Background: A recently registered device containing 80 mg of adalimumab (ADA) allows an alternative dose escalation regimen with ADA 80 mg every other week…”
Get full text

Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients by Gutiérrez, Ana, Zapater, Pedro, Ricart, Elena, González-Vivó, María, Gordillo, Jordi, Olivares, David, Vera, Isabel, Mañosa, Míriam, Gisbert, Javier P, Aguas, Mariam, Sánchez-Rodríguez, Eugenia, Bosca-Watts, Maia, Laredo, Viviana, Camps, Blau, Marín-Jiménez, Ignacio, Zabana, Yamile, Martín-Arranz, María Dolores, Muñoz, Roser, Navarro, Mercè, Sierra, Eva, Madero, Lucía, Vela, Milagros, Pérez-Calle, José Lázaro, Sainz, Empar, Calvet, Xavier, Arias, Lara, Morales, Victor, Bermejo, Fernando, Fernández-Salazar, Luis, Van Domselaar, Manuel, De Castro, Luisa, Rodríguez, Cristina, Muñoz-Villafranca, Carmen, Lorente, Rufo, Rivero, Montserrat, Iglesias, Eva, Herreros, Belén, Busquets, David, Riera, Joan, Martínez-Montiel, María Pilar, Roldón, Marta, Roncero, Oscar, Hinojosa, Esther, Sierra, Mónica, Barrio, Jesús, De Francisco, Ruth, Huguet, José, Merino, Olga, Carpio, Daniel, Ginard, Daniel, Muñoz, Fernando, Piqueras, Marta, Almela, Pedro, Argüelles-Arias, Federico, Alcaín, Guillermo, Bujanda, Luis, Manceñido, Noemí, Lucendo, Alfredo J, Varela, Pilar, Rodríguez-Lago, Iago, Ramos, Laura, Sempere, Laura, Sesé, Eva, Barreiro-de Acosta, Manuel, Domènech, Eugeni, Francés, Rubén

“…Previous studies comparing immigrant ethnic groups and native patients with IBD have yielded clinical and phenotypic differences. To date, no study has focused…”
Get full text

Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis by Taxonera, Carlos, Rodríguez, Cristina, Bertoletti, Federico, Menchén, Luís, Arribas, Julia, Sierra, Mónica, Arias, Lara, Martínez-Montiel, Pilar, Juan, Alba, Iglesias, Eva, Algaba, Alicia, Manceñido, Noemí, Rivero, Montserrat, Barreiro-de Acosta, Manuel, López-Serrano, Pilar, Argüelles-Arias, Federico, Gutierrez, Ana, Busquets, David, Gisbert, Javier P, Olivares, David, Calvo, Marta, Alba, Cristina

“…Golimumab efficacy data in ulcerative colitis (UC) are limited to anti-tumor necrosis factor α (TNF)-naive patients. The aim of this study was to assess the…”
Get full text

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry by Casanova, María José, Chaparro, María, Mínguez, Miguel, Ricart, Elena, Taxonera, Carlos, García-López, Santiago, Guardiola, Jordi, López-San Román, Antonio, Iglesias, Eva, Beltrán, Belén, Sicilia, Beatriz, Vera, María Isabel, Hinojosa, Joaquín, Riestra, Sabino, Domènech, Eugeni, Calvet, Xavier, Pérez-Calle, José Lázaro, Martín-Arranz, María Dolores, Aldeguer, Xavier, Rivero, Montserrat, Monfort, David, Barrio, Jesús, Esteve, María, Márquez, Lucía, Lorente, Rufo, García-Planella, Esther, de Castro, Luisa, Bermejo, Fernando, Merino, Olga, Rodríguez-Pérez, Antonio, Martínez-Montiel, Pilar, Van Domselaar, Manuel, Alcaín, Guillermo, Domínguez-Cajal, Manuel, Muñoz, Carmen, Gomollón, Fernando, Fernández-Salazar, Luis, García-Sepulcre, Mariana Fe, Rodríguez-Lago, Iago, Gutiérrez, Ana, Argüelles-Arias, Federico, Rodriguez, Cristina, Rodríguez, Gloria Esther, Bujanda, Luis, Llaó, Jordina, Varela, Pilar, Ramos, Laura, Huguet, José María, Almela, Pedro, Romero, Patricia, Navarro-Llavat, Mercè, Abad, Águeda, Ramírez-de la Piscina, Patricia, Lucendo, Alfredo J, Sesé, Eva, Madrigal, Rosa Eva, Charro, Mara, García-Herola, Antonio, Pajares, Ramón, Khorrami, Sam, Gisbert, Javier P

“…Abstract Background The effectiveness of the switch to another anti–tumor necrosis factor (anti-TNF) agent is not known. The aim of this study was to analyze…”
Get full text

Chronic intestinal failure: an overview and future perspectives by López Romero-Salazar, Francisco, Martínez Montiel, Pilar, Lal, Simon

“…Intestinal failure (IF) is the inability of the gut to absorb necessary water, macronutrients, micronutrients, and electrolytes sufficient to sustain life and…”
Get full text

The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCU by Bastón-Rey, Iria, Rodríguez-Lago, Iago, Luque, Ana María, Caballol, Berta, Soutullo-Castiñeiras, Carlos, Bravo, Ana, Castaño, Andrés, Gros, Beatriz, Bernal, Lorena, Diz-Lois, María Teresa, Alonso-Galán, Horacio, Cañete, Fiorella, Castro, Beatriz, Pérez-Galindo, Pablo, González-Muñoza, Carlos, El Hajra, Ismael, Martínez-Montiel, Pilar, Alonso-Abreu, Inmaculada, Mesonero, Francisco, González-Vivo, María, Peries, Laia, Martín-Arranz, Eduardo, Abril, Carlos, Marín-Jiménez, Ignacio, Baltar, Ruth, Vicuña, Miren, Moreno, Nadia, Brunet, Eduard, Rubín de Célix, Cristina, Fajardo, Ingrid, Cruz, Noelia, Calvino-Suárez, Cristina, Rojas-Feria, María, Fernández-Clotet, Agnes, Gimeno-Torres, Marta, Nieto-Garcia, Laura, de la Iglesia, Daniel, Zabana, Yamile, Suárez-Ferrer, Cristina, Barreiro de Acosta, Manuel

“…Limited data are available on the outcome of inflammatory bowel disease (IBD) in patients with solid organ transplantation (SOT). We describe the natural…”
Get full text

Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial by López-Sanromán, Antonio, Vera-Mendoza, Isabel, Domènech, Eugeni, Taxonera, Carlos, Vega Ruiz, Vicente, Marín-Jiménez, Ignacio, Guardiola, Jordi, Castro, Luisa, Esteve, María, Iglesias, Eva, Ceballos, Daniel, Martínez-Montiel, Pilar, Gisbert, Javier P, Mínguez, Miguel, Echarri, Ana, Calvet, Xavier, Barrio, Jesús, Hinojosa, Joaquín, Martín-Arranz, María Dolores, Márquez-Mosquera, Lucía, Bermejo, Fernando, Rimola, Jordi, Pons, Vicente, Nos, Pilar

“…Postoperative recurrence of Crohn's disease [POR-CD] is almost certain if no prophylaxis is administered. Evidence for optimal treatment is lacking. Our aim…”
Get full text

Infliximab-Related Hepatitis: A Case Study and Literature Review by Colina, Francisco, Molero, Aída, Casís, Begoña, Martínez-Montiel, Pilar

Get full text

Ustekinumab for corticodependent immune-mediated colitis by pembrolizumab, an alternative for patients with concomitant liver injury by Fernández-Gordón Sánchez, Flor M, Gómez-Domínguez, Elena, Paredes Ruiz, Diana, Rodríguez Gil, Yolanda, Martín Algíbez, Ana, Fernández Vázquez, Inmaculada, Martínez Montiel, Pilar

“…Pembrolizumab, a programmed cell death receptor (PD-1) inhibitor, have improved the prognosis in several types of cancer. Despite the important clinical…”
Get full text

Delphi consensus statement: Quality indicators for Inflammatory Bowel Disease Comprehensive Care Units by Calvet, Xavier, Panés, Julián, Alfaro, Noelia, Hinojosa, Joaquin, Sicilia, Beatriz, Gallego, Marta, Pérez, Ildefonso, Lázaro y de Mercado, Pablo, Gomollón, Fernando, Aldeguer, Physicians: Xavier, Alós, Rafael, Andreu, Montserrat, Barreiro, Manu, Bermejo, Fernando, Casis, Begoña, Domenech, Eugeni, Espín, Eloy, Esteve, Maria, García-Sánchez, Valle, López-Sanromán, Antonio, Martínez-Montiel, Pilar, Mendoza, Juan Luis, Gisbert, Javier P., Vera, Maribel, Dosal, Nurses: Angelina, Sánchez, Elena, Marín, Laura, Sanromán, Luciano, Pinilla, Pilar, Murciano, Francisca, Torrejón, Antonio, García, Patients (ACCU España): José Ramón, Ortega, Mayte, Roldán, Julio

“…While it is commonly accepted that Inflammatory bowel disease (IBD) Comprehensive Care Units (ICCUs) facilitate the delivery of quality care to Crohn's disease…”
Get full text

Safety of propofol sedation directed by endoscopists: how long should we continue to generate evidence? by Marín-Gabriel, José Carlos, Martínez-Montiel, Pilar

“…The administration of propofol by endoscopists is a source of permanent friction with the Societies of Anesthesiology, which is based more on a clear conflict…”
Get full text

Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases by Guerra, Iván, Algaba, Alicia, Pérez-Calle, José Lázaro, Chaparro, María, Marín-Jiménez, Ignacio, García-Castellanos, Raquel, González-Lama, Yago, López-Sanromán, Antonio, Manceñido, Noemí, Martínez-Montiel, Pilar, Quintanilla, Elvira, Taxonera, Carlos, Villafruela, Mónica, Romero-Maté, Alberto, López-Serrano, Pilar, Gisbert, Javier P., Bermejo, Fernando

“…Anti-tumor necrosis factor (TNF)-alpha agents are widely used for the treatment of both inflammatory bowel disease (IBD) and psoriasis. Psoriatic skin lesions…”
Get full text

Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease by Taxonera, Carlos, Ponferrada, Ángel, Riestra, Sabino, Bermejo, Fernando, Saro, Cristina, Martín-Arranz, María Dolores, Cabriada, José Luis, Barreiro-de Acosta, Manuel, de Castro, María Luisa, López-Serrano, Pilar, Barrio, Jesús, Suarez, Cristina, Iglesias, Eva, Argüelles-Arias, Federico, Ferrer, Isabel, Marín-Jiménez, Ignacio, Hernández-Camba, Alejandro, Bastida, Guillermo, Van Domselaar, Manuel, Martínez-Montiel, Pilar, Olivares, David, Rivero, Montserrat, Fernandez-Salazar, Luis, Nantes, Óscar, Merino, Olga, Alba, Cristina, Gisbert, Javier P

“…To assess the likelihood of detecting latent tuberculosis infection [LTBI] by the positive conversion of a serial tuberculin skin test [TST] at 1 year in…”
Get full text